Artemether bioavailability after oral or intramuscular administration in uncomplicated falciparum malaria

Kamolrat Silamut1, Paul N Newton, Paktiya Teja-Isavadharm

  • 1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.

Insights

Oral artemether shows higher plasma concentrations and better antimalarial activity than intramuscular doses in acute malaria patients. This suggests oral administration is more effective for treating Plasmodium falciparum malaria.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Artemether is a crucial antimalarial drug.
  • Understanding its pharmacokinetics is vital for effective malaria treatment.
  • Plasmodium falciparum malaria remains a significant global health concern.

Purpose of the Study:

  • To compare the antimalarial activity of artemether after oral versus intramuscular administration.
  • To evaluate artemether's plasma concentrations and pharmacokinetic parameters in acute malaria.

Main Methods:

  • Bioassay of artemether in plasma from 15 adults with acute uncomplicated Plasmodium falciparum malaria.
  • Measurement of peak plasma concentrations (Cmax), area under the curve (AUC(0-24)), and clearance (CL/F).
  • Comparison of parameters between acute and convalescent phases, and between oral and intramuscular routes.

Main Results:

  • Oral artemether resulted in significantly higher peak plasma concentrations (median 16x) and AUC(0-24) (median 3.3x) compared to intramuscular administration.
  • Plasma concentrations were higher and clearance was lower in the acute phase versus the convalescent phase after oral dosing.
  • Time to peak concentration was significantly shorter with oral (median 1 hr) than intramuscular (median 8 hr) artemether.

Conclusions:

  • Oral artemether demonstrates superior antimalarial activity and pharmacokinetic profile compared to intramuscular administration in acute malaria.
  • Intramuscular artemether absorption is notably slow in patients with acute malaria.
  • These findings support the efficacy of oral artemether for treating Plasmodium falciparum malaria.

Related Concept Videos

Bioavailability: Overview01:13

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
Bioavailability: Overview01:17

Bioavailability: Overview

Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Factors Influencing Drug Absorption: Presystemic Elimination01:24

Factors Influencing Drug Absorption: Presystemic Elimination

The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
First Pass Effect01:12

First Pass Effect

Presystemic elimination, or the first-pass effect, is the metabolism of drugs that reduces their effective concentration at the site of action. Apart from the first-pass effect, the systemic bioavailability of the drug is also reduced by other factors, including incomplete absorption or chemical degradation of drugs.
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...